Cargando…

Effect of acute and chronic graft-versus-host disease on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma

We evaluated the effect of acute and chronic graft-versus-host disease (GVHD) on relapse and survival after allogeneic haematopoietic stem cell transplantation (HSCT) for multiple myeloma (MM) using non-myeloablative conditioning (NMA) and reduced-intensity conditioning (RIC). The outcomes of 177 HL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ringdén, Olle, Shrestha, Smriti, da Silva, Gisela Tunes, Zhang, Mei-Jie, Dispenzieri, Angela, Remberger, Mats, Kamble, Rammurti, Freytes, Cesar O., Gale, Robert Peter, Gibson, John, Gupta, Vikas, Holmberg, Leona, Lazarus, Hillard, McCarthy, Philip, Meehan, Kenneth, Schouten, Harry, Milone, Gustavo A., Lonial, Sagar, Hari, Parameswaran N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369112/ https://www.ncbi.nlm.nih.gov/pubmed/21946381 http://dx.doi.org/10.1038/bmt.2011.192

Ejemplares similares

SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING AFTER A PRIOR AUTOTRANSPLANT – REDUCED INTENSITY ALLOGENEIC VERSUS AUTOLOGOUS TRANSPLANTATION
por: Freytes, Cesar O., et al.
Publicado: (2013)

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan‐Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation
por: El‐Serafi, Ibrahim, et al.
Publicado: (2019)

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma
por: Klyuchnikov, Evgeny, et al.
Publicado: (2015)

Hematopoietic Cell Transplantation for Primary Plasma Cell Leukemia: Results from the Center for International Blood and Marrow Transplant Research
por: Mahindra, Anuj, et al.
Publicado: (2011)

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft‐versus‐host disease prophylaxis
por: Garming Legert, Karin, et al.
Publicado: (2020)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR MYCOSIS FUNGOIDES AND SEZARY SYNDROME
por: Lechowicz, Mary Jo, et al.
Publicado: (2014)

Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection
por: Sparrelid, E, et al.
Publicado: (1998)

Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome
por: Goyal, Sagun D., et al.
Publicado: (2015)

Placenta‐Derived Decidua Stromal Cells for Treatment of Severe Acute Graft‐Versus‐Host Disease
por: Ringden, Olle, et al.
Publicado: (2018)

Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time
por: Kumar, Shaji K, et al.
Publicado: (2017)

Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
por: Olsson, Richard F., et al.
Publicado: (2015)

SIMILAR OUTCOMES USING MYELOABLATIVE VERSUS REDUCED INTENSITY ALLOGENEIC TRANSPLANT PREPARATIVE REGIMENS FOR AML OR MDS
por: Luger, Selina M., et al.
Publicado: (2011)

Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation
por: Poiret, Thomas, et al.
Publicado: (2018)

IS THE INTERNATIONAL STAGING SYSTEM SUPERIOR TO THE DURIE SALMON STAGING SYSTEM? A COMPARISON IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT
por: Hari, Parameswaran N., et al.
Publicado: (2009)

Continuous Immune Cell Differentiation Inferred From Single-Cell Measurements Following Allogeneic Stem Cell Transplantation
por: Chen, Yang, et al.
Publicado: (2018)

Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation
por: Cheng, Yee Chung, et al.
Publicado: (2017)

Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults
por: Poiret, Thomas, et al.
Publicado: (2014)

Liaisons Dangereuses? new drugs, physicians and the drug industry
por: Gale, Robert Peter, et al.
Publicado: (2020)

Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation
por: Solders, Martin, et al.
Publicado: (2017)

A Phase 3, Randomized, Placebo-controlled Trial of Filgrastim in Patients with Haematological Malignancies Undergoing Matched-related Allogeneic Bone Marrow Transplantation
por: Ernst, Peter, et al.
Publicado: (2008)

Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: A Center for International Blood and Marrow Transplant Research Analysis
por: Mahindra, Anuj, et al.
Publicado: (2017)

Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents
por: Shah, Nishi, et al.
Publicado: (2014)

Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning
por: Li, Qin, et al.
Publicado: (2016)

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
por: Maffini, Enrico, et al.
Publicado: (2019)

Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
por: Baygan, Arjang, et al.
Publicado: (2017)

Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
por: Ringdén, Olle, et al.
Publicado: (2020)

Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
por: Lazarus, Hillard M., et al.
Publicado: (2021)

Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
por: Afram, Gabriel, et al.
Publicado: (2018)

Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
por: Ringdén, Olle, et al.
Publicado: (2022)

Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review
por: Sadeghi, Behnam, et al.
Publicado: (2022)

Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial
por: Malek, Ehsan, et al.
Publicado: (2023)

Letter to the Editor Regarding “Diagnostic Considerations for COVID-19 in Recipients of Allogeneic Hematopoietic Cell Transplantation”
por: Chhabra, Saurabh, et al.
Publicado: (2020)

PB2463: PROTRACTED DIARRHEA FROM HIGH-DOSE MELPHALAN IN AUTOLOGOUS HEMATOPOIETIC TRANSPLANTATION: RESPONSE TO SHORT COURSE OF ORAL BUDESONIDE
por: Kamble, Rammurti, et al.
Publicado: (2023)

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
por: Murthy, Guru Subramanian Guru, et al.
Publicado: (2023)

Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
por: Hamdan, Hamdan, et al.
Publicado: (2021)

Assessment and reporting of quality-of-life measures in pivotal clinical trials of hematological malignancies
por: Al Hadidi, Samer, et al.
Publicado: (2021)

Clinical uses of GM-CSF, a critical appraisal and update
por: Arellano, Martha, et al.
Publicado: (2008)

When an embarrassment of riches isn’t enough
por: Patel, Krina, et al.
Publicado: (2022)

Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
por: Massoud, Mira Romany, et al.
Publicado: (2016)

Thrombotic Microangiopathy in Haematopoietic Cell Transplantation: an Update
por: Stavrou, Evi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_drklfb1jr8qcfakm0lftq4o56t